​

Funding Round

Series E - Chiasma

Series E - Chiasma

Investment Firm

Overview

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

Announced Date

Feb 27, 2015

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorSofinnova Investments
Participant InvestorMPM Capital
Participant InvestorAbingworth
Participant InvestorBlue Chip Venture Company
Participant InvestorARCH Venture Partners

Round Details and Background

Chiasma raised $70000000 on 2015-02-27 in Series E

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

Company Funding History

14

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 08, 2012
Debt Financing - Chiasma
-3.0M
Jun 14, 2011
Debt Financing - Chiasma
-10.0M
Sep 12, 2005
Series B - Chiasma
4-7.7M
Nov 15, 2006
Series C - Chiasma
4-44.0M

Recent Activity

There is no recent news or activity for this profile.